Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Other Accumulated Expenses (2017 - 2019)

Historic Other Accumulated Expenses for Macrogenics (MGNX) over the last 6 years, with Q3 2019 value amounting to $175000.0.

  • Macrogenics' Other Accumulated Expenses changed 0.0% to $175000.0 in Q3 2019 from the same period last year, while for Sep 2019 it was $175000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $175000.0 for FY2018, which is 6300.21% down from last year.
  • According to the latest figures from Q3 2019, Macrogenics' Other Accumulated Expenses is $175000.0, which was down 0.0% from $175000.0 recorded in Q2 2019.
  • Macrogenics' Other Accumulated Expenses' 5-year high stood at $1.6 million during Q1 2015, with a 5-year trough of $175000.0 in Q3 2017.
  • In the last 4 years, Macrogenics' Other Accumulated Expenses had a median value of $175000.0 in 2017 and averaged $570384.6.
  • Per our database at Business Quant, Macrogenics' Other Accumulated Expenses soared by 34224.62% in 2015 and then crashed by 6300.21% in 2018.
  • Over the past 4 years, Macrogenics' Other Accumulated Expenses (Quarter) stood at $727000.0 in 2015, then crashed by 34.94% to $473000.0 in 2017, then tumbled by 63.0% to $175000.0 in 2018, then changed by 0.0% to $175000.0 in 2019.
  • Its last three reported values are $175000.0 in Q3 2019, $175000.0 for Q2 2019, and $175000.0 during Q1 2019.